Associate professor, UCL
Mohlopheni Jackson Marakalala is an Associate Professor in the Division of Infection and Immunity at University College London. He heads a research group at Africa Health Research Institute, and holds an Honorary Research Associate affiliation with the University of Cape Town. He is also a Visiting Scientist at Harvard School of Public Health, where he recently completed a 4 year postdoctoral fellowship in infectious diseases. He is one of the current Next Einstein Fellows, and was recently honored by World Economic Forum as a Young Scientist. Mohlopheni hopes to discover new therapeutic and diagnostic tools to combat infectious diseases mostly prevalent in Sub-Saharan Africa. His laboratory research focuses on the development of better therapies against Tuberculosis. He hopes to contribute towards public dialogues that will help inform better health policies. He also envisions building research capacity in Africa by training PhD students from disadvantaged communities.
Scientists are developing new, exciting strategies for the fight against TB
Apr 01, 2019 17:26 pm UTC| Insights & Views Science
Tuberculosis (TB) is a lung disease caused by the bacterium Mycobacterium tuberculosis. Its transmitted through air droplets when an infectious person coughs or sneezes. The disease can be treated, but its a long process...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight